Eagle Global Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-2,740
Closed -$244K 257
2018
Q1
$244K Sell
2,740
-94,835
-97% -$9.1M 0.01% 216
2017
Q4
$10.2M Sell
97,575
-2,060
-2% -$232K 0.32% 60
2017
Q3
$14.5M Buy
99,635
+35
+0% +$4.77K 0.44% 43
2017
Q2
$12.9M Sell
99,600
-860
-0.9% -$105K 0.37% 48
2017
Q1
$12.5M Sell
100,460
-1,030
-1% -$123K 0.34% 49
2016
Q4
$11.7M Sell
101,490
-6,540
-6% -$728K 0.32% 56
2016
Q3
$11.3M Sell
108,030
-6,485
-6% -$702K 0.32% 59
2016
Q2
$11.3M Sell
114,515
-265
-0.2% -$27.4K 0.33% 57
2016
Q1
$11.5M Sell
114,780
-610
-0.5% -$62.8K 0.41% 53
2015
Q4
$13.8M Buy
115,390
+7,405
+7% +$857K 0.48% 48
2015
Q3
$11.7M Sell
107,985
-35
-0% -$4.34K 0.39% 53
2015
Q2
$12.5M Buy
108,020
+4,225
+4% +$483K 0.32% 55
2015
Q1
$12M Sell
103,795
-285
-0.3% -$34.1K 0.31% 53
2014
Q4
$11.6M Sell
104,080
-915
-0.9% -$96.5K 0.3% 55
2014
Q3
$9.95M Sell
104,995
-255
-0.2% -$23K 0.24% 65
2014
Q2
$9.04M Sell
105,250
-6,260
-6% -$476K 0.23% 69
2014
Q1
$7.78M Buy
111,510
+29,260
+36% +$2.32M 0.24% 75
2013
Q4
$6.95M Buy
+82,250
New +$6.51M 0.22% 89

Other funds holding CELG

Eagle Global Advisors's CELG Position: Q2 2018 in Review

Eagle Global Advisors sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 2,740 shares — an estimated $244K sold.

Eagle Global Advisors first reported a position in CELG in Q4 2013 and held it in 18 quarters. The position peaked at $14.5M in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Eagle Global Advisors reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Eagle Global Advisors sold 2,740 Celgene Corp shares in Q2 2018, an estimated $244K.
  • Eagle Global Advisors first reported a position in Celgene Corp in Q4 2013 and held it in 18 quarters.
  • Eagle Global Advisors's Celgene Corp position peaked at $14.5M in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Eagle Global Advisors's 13F filing for Q2 2018, filed 1 Aug 2018.